Evidence map›Paper›PMID 41509903›Full record

ArticleiScience2026

Otic organoids: A model to study spiral ganglion neuron characteristics in Tmprss3-deficiency.

André U Deutschmann, Lucie Pifkova, Betül Findik, Moritz Klingenstein, Anton Betz, Maksim Klimiankou, Julia Skokowa, Stefan Liebau, Ellen Reisinger, Stefanie Klingenstein

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

André U DeutschmannGene Therapy for Hearing Impairment and Deafness, Department for Otolaryngology, Head and Neck Surgery, University Hospital Tübingen, Tübingen, Germany.
Lucie PifkovaGene Therapy for Hearing Impairment and Deafness, Department for Otolaryngology, Head and Neck Surgery, University Hospital Tübingen, Tübingen, Germany.
Betül FindikDepartment of Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
Moritz KlingensteinInstitute of Neuroanatomy and Developmental Biology (INDB), Eberhard Karls University Tübingen, Tübingen, Germany.
Anton BetzInstitute of Neuroanatomy and Developmental Biology (INDB), Eberhard Karls University Tübingen, Tübingen, Germany.
Maksim KlimiankouDepartment of Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
Julia SkokowaDepartment of Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
Stefan LiebauInstitute of Neuroanatomy and Developmental Biology (INDB), Eberhard Karls University Tübingen, Tübingen, Germany.
Ellen ReisingerGene Therapy for Hearing Impairment and Deafness, Department for Otolaryngology, Head and Neck Surgery, University Hospital Tübingen, Tübingen, Germany.
Stefanie KlingensteinInstitute of Neuroanatomy and Developmental Biology (INDB), Eberhard Karls University Tübingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organoids are valuable models to study human diseases. Cochlear implants (CIs) electrically stimulate spiral ganglion neurons (SGNs) to enable severely hearing-impaired people vocal communication. However, some studies found in patients with mutations in the TMPRSS3 gene that speech comprehension with CI was lower than for other etiologies. The reduced CI performance might be associated with reduced SGN excitability, the causes for which are largely unclear. We refined a protocol for generating SGN-like cells in otic organoids from human induced pluripotent stem cells (iPSC) and confirmed their identity through marker expression and electrophysiological characterization. TMPRSS3-deficient iPSC clones developed smaller and less differentiated organoids. Moreover, TMPRSS3-deficient SGN-like cells displayed smaller currents and were less likely to exhibit action potentials, which recapitulate the expected disease phenotype. Ultimately, we seek to use this organoid model to study SGN function in human patients for enhancing our understanding and prediction of CI performance.

Indexed as

cell biologyneuroscience

Identifiers

PMID41509903
PMCPMC12775872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.